The International Network on Hepatitis in Substance Users (INHSU) is an international, not-for-profit, member-based organization dedicated to scientific knowledge exchange, education, and advocacy focused on hepatitis C (HCV) prevention and care with people who use drugs.
Globally, HCV related morbidity and mortality is rising with people who inject drugs (PWID) accounting for the majority of new (90%) and existing (65-70%) cases of HCV in many high- and middle-income countries. However, following the advent of well-tolerated, simple, short-course direct acting antiviral (DAA) interferon-free HCV regimens with cure rates >95%, there is potential to reverse the rising burden of advanced liver disease with increased treatment.
For more information on the International Network on Hepatitis in Substance Users please visit the website www.inhsu.org
Hosted by INHSU the conference covers the latest advances on hepatitis C epidemiology, management and treatment of viral hepatitis among people who use drugs, with a specific focus on hepatitis C. Through dissemination of scientific knowledge, the conference aims to contribute to the World Health Organization’s goal of eliminating hepatitis C by 2030.
The conference has a truly international focus attracting delegates from around the world, including health professionals (doctors, nurses and allied health), researchers, representatives from community organisations, people who use drugs and policy makers.
2009: Zurich, Switzerland
2011: Brussels, Belgium
2013: Munich, Germany
2015: Sydney, Australia
2016: Oslo, Norway
2017: Jersey City, United States
2018: Cascais, Portugal